GL1X · GenesisL1 explorer

Ligand · BF0

BF0 · methyl 4-{[(5beta,6alpha)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]amino}-4-oxobutanoate

BF0, methyl 4-{[(5beta,6alpha)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]amino}-4-oxobutanoate (C25 H32 N2 O6, 456.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…

Component
BF0
Formula
C25 H32 N2 O6
Class
ligand
Structures
2
PDB entries
1

Binding sites

BF0 in 2 structures; the first of them:

  • 4DKL · Crystal structure of the mu-opioid receptor bound to a morphinan antagonist · BF0 A601 · binds ASP147, TYR148, MET151, GLU229, LYS233, VAL236, TRP293, ILE296 and 7 more
  • 4DKL · Crystal structure of the mu-opioid receptor bound to a morphinan antagonist · BF0 A601 · binds ASP147, TYR148, MET151, GLU229, LYS233, VAL236, TRP293, ILE296 and 7 more

Residues it binds most

ILE 2, LYS 2, TRP 2, TYR 2, VAL 2, ASP 2, GLU 2, GLY 2, HIS 2, MET 2 (residue and the binding sites it lines).

Found with

  • CLR · Cholesterol
  • MPG · [(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate
  • CL · Chloride ion
  • SO4 · Sulfate ion
  • 1PE · Pentaethylene glycol

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.